Preclinical Testing Demonstrates Striking Efficacy of STA-12-8666, an Hsp90 Inhibitor-Targeted SN-38 Conjugate, in Small Cell Lung Cancer

被引：0
|
作者：
Boumber, Y. [1 ]
Gaponova, A. [1 ]
Nikonova, A. S. [1 ]
Deneka, A. [1 ]
Kudinov, A. [1 ]
Chikwem, A. [1 ]
Egleston, B. L. [1 ]
Litwin, S. [1 ]
Duncan, J. S. [1 ]
Duncan, K. [1 ]
Borghaei, H. [1 ]
Mehra, R. [1 ]
Proia, D. [2 ]
Golemis, E. [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Synta Pharmaceut, Lexington, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.08.287
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
247
引用
收藏
页码：S64 / S65
页数：2
相关论文
共 14 条
  • [1] Preclinical efficacy of STA-12-8666, an HSP90 inhibitor-targeted SN-38 conjugate, in small cell lung cancer (SCLC).
    Boumber, Yanis
    Gaponova, Anna
    Nikonova, Anna S.
    Deneka, Alexander
    Kudinov, Alexander
    Egleston, Brian L.
    Duncan, James S.
    Duncan, Kelly
    Borghaei, Hossein
    Mehra, Ranee
    Proia, David A.
    Golemis, Erica
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Preclinical testing demonstrates strong activity of STA-12-8666, an HSP90 inhibitor-SN-38 conjugate, in small cell lung cancer (SCLC)
    Gaponova, Anna
    Nikonova, A. S.
    Deneka, A.
    Egleston, B. L.
    Litwin, S.
    Duncan, J. S.
    Duncan, K.
    Borghaei, H.
    Mehra, R.
    Proia, D. A.
    Boumber, Y.
    Golemis, Erica
    CANCER RESEARCH, 2015, 75
  • [3] The Novel HSP90 Inhibitor-SN-38 Conjugate (STA-12-8666), Is Highly Active in Preclinical Models of Small Cell Lung Cancer (SCLC)
    Boumber, Yanis
    Gaponova, Anna
    Nikonova, Anna
    Deneka, Alexander
    Kudinov, Alexander
    Kopp, Meghan
    Egleston, Brian L.
    Litwin, Sam
    Duncan, James S.
    Duncan, Kelly
    Borghaei, Hossein
    Mehra, Ranee
    Proia, David
    Golemis, Erica
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S399 - S399
  • [4] Hsp90-inhibitor drug conjugate STA-12-8666 demonstrates complete tumor regression in preclinical models of pediatric sarcoma
    Heske, Christine M.
    Mendoza, Arnulfo
    Yeung, Choh
    Proia, David A.
    Neckers, Len
    Helman, Lee J.
    CANCER RESEARCH, 2016, 76
  • [5] STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma
    Heske, Christine M.
    Mendoza, Arnulfo
    Edessa, Leah D.
    Baumgart, Joshua T.
    Lee, Sunmin
    Trepel, Jane
    Proia, David A.
    Neckers, Len
    Helman, Lee J.
    ONCOTARGET, 2016, 7 (40) : 65540 - 65552
  • [6] Activity of Hsp90-inhibitor drug conjugate (HDC) STA-12-8666 in preclinical models of pediatric sarcoma.
    Heske, Christine
    Mendoza, Arnulfo
    Yeung, Choh
    Proia, David A.
    Neckers, Len
    Helman, Lee J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] STA-12-8666: a first-in-class HSP90 inhibitor drug conjugate (HDC) designed to selectively deliver chemotherapy to tumors
    Proia, David A.
    Smith, Donald L.
    Zhang, Junyi
    Zhou, Dan
    Jimenez, John-Paul
    Sang, Jim
    Rippy, Sarah
    London, Cheryl
    Ogawa, Luisa S.
    Jiang, Jun
    Przewloka, Teresa
    Sequeira, Manuel
    Acquaviva, Jaime
    He, Suqin
    Chu, John
    Zhang, Chaohua
    Liu, Yuan
    Ye, Josephine
    Khazak, Vladimir
    Astsaturov, Igor
    Inoue, Takayo
    Tatsuta, Noriaki
    Bates, Richard C.
    Sonderfan, Andrew
    Chimmanamada, Dinesh
    Ying, Weiwen
    CANCER RESEARCH, 2015, 75
  • [8] A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
    Gaponova, Anna V.
    Nikonova, Anna S.
    Deneka, Alexander Y.
    Kopp, Meghan C.
    Kudinov, Alexander E.
    Skobeleva, Natalia
    Khazak, Vladimir
    Ogawa, Luisa S.
    Cai, Kathy Q.
    Duncan, Kelly E.
    Duncan, James S.
    Egleston, Brian L.
    Proia, David A.
    Boumber, Yanis
    Golemis, Erica A.
    CLINICAL CANCER RESEARCH, 2016, 22 (20) : 5120 - 5129
  • [9] Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non-Small Cell Lung Cancer
    Sang, Jim
    Acquaviva, Jaime
    Friedland, Julie C.
    Smith, Donald L.
    Sequeira, Manuel
    Zhang, Chaohua
    Jiang, Qin
    Xue, Liquan
    Lovly, Christine M.
    Jimenez, John-Paul
    Shaw, Alice T.
    Doebele, Robert C.
    He, Suqin
    Bates, Richard C.
    Camidge, D. Ross
    Morris, Stephan W.
    El-Hariry, Iman
    Proia, David A.
    CANCER DISCOVERY, 2013, 3 (04) : 430 - 443
  • [10] A Phase II Study Of The Hsp90 Inhibitor STA-9090 Administered To Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
    Goldman, J.
    Paschold, E. H.
    Webb, T.
    Chen, L.
    Kozcywas, M.
    Lufkin, J. M.
    Vukovic, V.
    Shapiro, G. I.
    Socinski, M. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S560 - S560
12